Morgan Stanley Equalweight on MedAssets

Morgan Stanley is out with a research report on MedAssets Inc. MDAS and it has a Equal-Weight rating on shares. In a note to clients, Morgan Stanley writes, "MedAssets reported strong 3Q11 results due largely to ~$3.0 mil (~$0.03/share after-tax) of milestone performance payments from the Texas Purchasing Coalition expected in 4Q being accelerated into 3Q. Revenues of $143.7 mil exceeded MS of $137.3 mil and consensus of $137.4 mil, and adjusted EPS of $0.26 well exceeded MS and consensus of $0.16 even after the ~$0.03 benefit of a lower tax rate." Shares of MDAS lost 40 cents yesterday to close at $10.36.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!